Mesa Biotech Receives FDA 510(k) Clearance and CLIA Waiver for Its Accula™ Point of Care Flu A/Flu B Test

February 7, 2018

Responsive image

SAN DIEGO, Feb. 7, 2018 /PRNewswire/ — Mesa Biotech Inc., a privately held, molecular diagnostic company that has developed an affordable PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced that it…

Category: Precious Metals